The market was most recently valued at $105.4 million in 2023, according to a Jan. 2 news release from Future Market Insights. The United States market is expected to reach $61.8 million by 2033, with a compound annual growth rate of 6%.
FMI attributed the growth to the increased prevalence of fentanyl abuse around the world, in addition to growing harm reduction efforts and government regulations emphasizing fentanyl testing in places like addiction treatment centers and emergency settings, the release said.
At the Becker's Fall Behavioral Health Summit, taking place October 20–22 in Chicago, behavioral health leaders and executives will explore strategies for expanding access to care, integrating services, addressing workforce challenges and leveraging innovation to improve outcomes across the behavioral health continuum. Apply for complimentary registration now.
